ANL logo

ANL Stock Overview

Profile

Full Name:

Adlai Nortye Ltd.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Cayman Islands

IPO:

September 23, 2023

Indexes:

Not included

Website:

http://www.adlainortye.com

Description:

Adlai Nortye American Depositary Shares (ANL) focuses on developing innovative cancer therapies. The company specializes in creating treatments for various types of cancer, aiming to improve patient outcomes through advanced research and development in oncology.

Key Details

Price

$2.20

Market Cap

$81.18 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$5.00 M

Annual EPS

-$7.26(-355.69% YoY)

PE Ratio

-

Annual ROE

-132.07%

Annual Debt To Equity

0.38

Beta

0.45

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 21, 2025

Recent annual earnings:

Apr 22, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 11, 24 HC Wainwright & Co.
Buy
Oct 18, 24 HC Wainwright & Co.
Buy
Sep 4, 24 HC Wainwright & Co.
Buy
Jun 20, 24 Cantor Fitzgerald
Overweight
Oct 24, 23 Cantor Fitzgerald
Overweight

Screeners with ANL included

Stocks below SMA 200
Most recommended stocks
Earnings today
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
All stocks
Earnings this week
Biotechnology industry
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$2.20
ANL price is $2.20

Price All-time High

$15.00
ANL price is currently -85.33% below its historical high of $15.00

Price Analysts Target

$9.00
ANL price is currently -75.56% lower than the consensus analysts' forecast

Price Most Recent Change

+0.92%
ANL price was up +0.92% on Feb 21, 2025

Price YTD Change

-18.52%
ANL price is down -18.52% since January 1st

Price 3-Year Change

-
ANL price 3-year change is unknown

Market cap

Market Cap

$81.18 M
ANL market capitalization is $81.18 million

Market Cap 3-Year Change

-
ANL market capitalization 3-year change is unknown

Market Cap All-time High

$553.50 M
ANL market capitalization is currently -85.33% below its historical high of $553.50 million

Market Cap Sector Rank

42.11%
ANL market capitalization is higher than 42.11% of companies in Healthcare sector

Technical

Beta

0.45
ANL beta is 0.45

200-day SMA

$3.53
ANL price is currently -37.61% below its 200-day simple moving average

14-day RSI

55.75
ANL 14-day relative strength index is 55.75

30-day Relative Volume

1.47
ANL 30-day relative volume is 1.47

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$5.00 M
ANL annual revenue is $5.00 million

Annual Revenue Analysts Estimate

-
ANL annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
ANL annual revenue 1-year change is unknown

Annual Revenue Sector Rank

22.43%
ANL annual revenue is higher than 22.43% of companies in Healthcare sector

Profit

Annual Gross Profit

-
ANL annual gross profit value is unknown

Annual Gross Margin

-
ANL annual gross profit margin value is unknown

Annual Operating Profit

-$67.55 M
ANL annual operating income is -$67.55 million

Annual Operating Margin

-1351.02%
ANL annual operating profit margin is -1351.02%

Annual Net Income

-$104.87 M
ANL annual net profit is -$104.87 million

Annual Net Margin

-2097.42%
ANL annual net profit margin is -2097.42%

EPS

Annual EPS

-$7.26
ANL annual earnings per share is -$7.26

Annual EPS Analysts Estimate

-$0.88
ANL annual earnings per share is currently +725.00% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-355.69%
ANL annual earnings per share is down -355.69% year-on-year

Annual EPS Sector Rank

17.75%
ANL annual earnings per share is higher than 17.75% of companies in Healthcare sector

ROA & ROE

Annual ROA

-103.43%
ANL annual return on assets is -103.43%

Annual ROE

-132.07%
ANL annual return on equity is -132.07%

EBIT & EBITDA

Annual EBIT

-$103.44 M
ANL annual earnings before interest & taxes is -$103.44 million

Annual EBITDA

-$101.22 M
ANL annual EBITDA is -$101.22 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ANL price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ANL price to earnings ratio is unknown

PB Ratio

PB Ratio

1.52
ANL price to book ratio is 1.52

PB Ratio Sector Rank

50.78%
ANL price to book ratio is higher than 50.78% of companies in Healthcare sector

PS Ratio

PS Ratio

-
ANL price to sales ratio value is unknown

PS Ratio Sector Rank

-
ANL price to sales ratio is unknown

Enterprise value

Enterprise Value

$22.73 M
ANL enterprise value is $22.73 million

Enterprise Value Sector Rank

29.94%
ANL enterprise value is higher than 29.94% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
ANL EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
ANL EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.01
ANL annual current ratio is 2.01

Annual Quick Ratio

-
ANL annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.38
ANL annual debt to equity ratio is 0.38

Annual Interest Coverage Ratio

-130.77
ANL annual interest coverage ratio is -130.77

Risk & Stability

Piotroski F-Score

-
ANL piotroski f-score value is unknown

Altman Z-Score

-5.17
ANL altman z-score is -5.17

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$130.19 M
ANL annual total assets is $130.19 million

Annual Non Current Assets

$28.99 M
ANL annual long term assets is $28.99 million

Annual Current Assets

$101.19 M
ANL annual total current assets is $101.19 million

Annual Cash & Cash Equivalents

$91.49 M
ANL annual cash & cash equivalents is $91.49 million

Equity

Annual Book Value

$79.40 M
ANL annual book value is $79.40 million

Annual Working Capital

$50.88 M
ANL annual working capital is $50.88 million

Liabilities

Annual Total Liabilities

$50.79 M
ANL annual total liabilities is $50.79 million

Annual Total Long Term Liabilities

$469.00 K
ANL annual total long term liabilities is $469.00 thousand

Annual Current Liabilities

$50.32 M
ANL annual total current liabilities is $50.32 million

Annual Accounts Payable

$14.35 M
ANL annual accounts payable is $14.35 million

Debt

Annual Total Debt

$31.55 M
ANL annual total debt is $31.55 million

Annual Total Debt 1-Year Change

+382.09%
ANL annual total debt is up +382.09% year-on-year

Annual Long Term Debt

$469.00 K
ANL annual long term debt is $469.00 thousand

Annual Short Term Debt

$31.08 M
ANL annual short term debt is $31.08 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$72.55 M
ANL annual total expenses is $72.55 million

Annual Operating Expenses

$72.55 M
ANL annual total operating expenses is $72.55 million

Annual Cost Of Goods Sold

-
ANL annual cost of goods sold value is unknown

Annual SGA

$15.29 M
ANL annual SGA is $15.29 million

Annual D&A

$2.22 M
ANL annual depreciation & amortization is $2.22 million

Annual Interest Expense

$791.00 K
ANL annual interest expense is $791.00 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$56.65 M
ANL annual cash flow from operations is -$56.65 million

Annual CFO 1-Year Change

-31.07%
ANL annual cash flow from operations is down -31.07% year-on-year

Annual CFI

-$10.95 M
ANL annual cash flow from investing activities is -$10.95 million

Annual CFI 1-Year Change

-138.6%
ANL annual cash flow from investing activities is down -138.6% year-on-year

Annual CFF

$116.24 M
ANL annual cash flow from financing activities is $116.24 million

Annual CFF 1-Year Change

+1814.45%
ANL annual cash flow from financing activities is up +1814.45% year-on-year

Free CashFlow

Annual FCF

-$56.85 M
ANL annual free cash flow is -$56.85 million

Annual FCF 1-Year Change

-27.78%
ANL annual free cash flow is down -27.78% year-on-year

CAPEX

Annual CAPEX

$200.00 K
ANL annual capital expenditures is $200.00 thousand

Annual CAPEX 1-Year Change

-84.23%
ANL annual capital expenditures is down -84.23% year-on-year

Institutional Ownership

Similar stocks

IGMS logo
IGM Biosciences (IGMS)
ADVM logo
Adverum Biotechnologies (ADVM)
XTNT logo
Xtant Medical Holdings (XTNT)
ICCM logo
IceCure Medical Ltd (ICCM)
INZY logo
Inozyme Pharma (INZY)
HYPR logo
Hyperfine (HYPR)
XFOR logo
X4 Pharmaceuticals (XFOR)
INO logo
Inovio Pharmaceuticals (INO)
ACET logo
Adicet Bio (ACET)

FAQ

  • What is the ticker symbol for Adlai Nortye American Depositary Shares?
  • Does Adlai Nortye American Depositary Shares pay dividends?
  • What sector is Adlai Nortye American Depositary Shares in?
  • What industry is Adlai Nortye American Depositary Shares in?
  • What country is Adlai Nortye American Depositary Shares based in?
  • When did Adlai Nortye American Depositary Shares go public?
  • Is Adlai Nortye American Depositary Shares in the S&P 500?
  • Is Adlai Nortye American Depositary Shares in the NASDAQ 100?
  • Is Adlai Nortye American Depositary Shares in the Dow Jones?
  • When was Adlai Nortye American Depositary Shares's last earnings report?
  • When does Adlai Nortye American Depositary Shares report earnings?
  • Should I buy Adlai Nortye American Depositary Shares stock now?

What is the ticker symbol for Adlai Nortye American Depositary Shares?

The ticker symbol for Adlai Nortye American Depositary Shares is NASDAQ:ANL

Does Adlai Nortye American Depositary Shares pay dividends?

No, Adlai Nortye American Depositary Shares does not pay dividends

What sector is Adlai Nortye American Depositary Shares in?

Adlai Nortye American Depositary Shares is in the Healthcare sector

What industry is Adlai Nortye American Depositary Shares in?

Adlai Nortye American Depositary Shares is in the Biotechnology industry

What country is Adlai Nortye American Depositary Shares based in?

Adlai Nortye American Depositary Shares is headquartered in Cayman Islands

When did Adlai Nortye American Depositary Shares go public?

Adlai Nortye American Depositary Shares's initial public offering (IPO) was on September 23, 2023

Is Adlai Nortye American Depositary Shares in the S&P 500?

No, Adlai Nortye American Depositary Shares is not included in the S&P 500 index

Is Adlai Nortye American Depositary Shares in the NASDAQ 100?

No, Adlai Nortye American Depositary Shares is not included in the NASDAQ 100 index

Is Adlai Nortye American Depositary Shares in the Dow Jones?

No, Adlai Nortye American Depositary Shares is not included in the Dow Jones index

When was Adlai Nortye American Depositary Shares's last earnings report?

Adlai Nortye American Depositary Shares's most recent earnings report was on Feb 21, 2025

When does Adlai Nortye American Depositary Shares report earnings?

The date for Adlai Nortye American Depositary Shares's next earnings report has not been announced yet

Should I buy Adlai Nortye American Depositary Shares stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions